von Willebrand factor, endothelial cell damage and atherosclerosis

European Journal of Vascular Surgery

Volumn 8, Issue 1, 1994, Pages 10-15

  Blann, Andrew D ^a   McCollum, Charles N ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Endothelial injury; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BLOOD LEVEL; CELL DAMAGE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBENDOTHELIUM; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMAN; MYOCARDIAL INFARCTION; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; VON WILLEBRAND FACTOR;

EID: 0028117398     PISSN: 0950821X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-821X(05)80112-4     Document Type: Review

References (93)

1. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
2. Monocytic origin of foam cells in human atherosclerotic plaques
3. The relationship between plasma and tissue lipids in human atherosclerosis
4. A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro
5. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis
6. The role of endothelial cell injury and platelet response in atherogenesis
7. The role of blood and platelets in atherosclerosis and the complications of atherosclerosis
8. Thromboatherosclerosis in normolipemic rabbits: a result of intimal endothelial cell damage
9. Participation of the endothelium in the development of the atherosclerotic plaque
10. The Pathogenesis of Atherosclerosis — An Update
11. Cell biology of endothelial cells
12. The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response
13. Hereditar pseudohamofili
14. Synthesis of antihemophilic factor by cultured human endothelial cells
15. Biosynthesis of von Willebrand protein by human megakaryocytes
16. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localisation
17. Composition of the von Willebrand factor storage organelle (WiebelPalade body) isolated from cultured human umbilical vein endothelial cells
18. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIII: RAg) in human platelet granules
19. Human von Willebrand factor: a multivalent protein composed of identical subunits
20. The von Willebrand factor in the vessel wall mediates platelet adherence
21. Cell Biology of Von Willebrand Factor
22. Interaction of purified type IIb von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation
23. Stabilisation of factor VIII in plasma by the von Willebrand factor
24. Association of the factor VIII light chain with von Willebrand factor
25. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells
26. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen
27. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells
28. Subcellular platelet factor VIII antigen and von Willebrand factor
29. von Willebrand's disease
30. Presence of factor VIII related antigen in blood platelets of patients with von Willebrand's disease
31. Immunological detection of activated platelets in clinical disorders
32. von Willebrand factor release induced by endotoxin
33. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis
34. Changes in factor VIII proteins after cardiopulmonary bypass in man suggests endothelial damage
35. Factor VIII complex and endothelial damage
36. Factor VIII antigen plasma levels in diabetes mellitus. Enhanced endothelial release and storage
37. Evidence for functional endothelial cell damage in early diabetic retinopathy
38. von Willebrand factor is an acute phase reactant in man
39. A comparative study using immunological and biological assays of the haemostatic responses to DDAVP infusion, venous occlusion and exercise in normal men
40. Changes in anti-hemophilic factor (AHF, Factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy and following exercise and pneumencephalography
41. Cytokine-mediated activation of vascular endothelium
42. Experimental arteriosclerosis. I. Fibrous plaque formation in primates. An electron microscope study
43. Role of immunologic arterial injury in atherogenesis
44. The role of endothelial cell injury and platelet response in atherogenesis
45. Role of von Willebrand factor in atherogenesis
46. Workshop V—What is a risk factor and what is not—Theoretical and practical implications
47. Lipids, diabetes and coronary heart disease. Insights from the Framingham study
48. Incidence of vascular disease in diabetic patients from ten international centres
49. Diabetes and atherosclerosis. An overview
50. Increased von Willebrand antihaemophilic factor A in diabetic retinopathy
51. Increased von Willebrand factor in diabetes mellitus
52. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?
53. Smoking: health effects and controls
54. Smoking and arterial disease-news of the old enemy
55. Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides
56. The effects of acute smoking on platelet behavior, fibrinolysis and haemorheology in habitual smokers
57. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma
58. The free radical chemistry of cigarette smoke and its toxicological implications
59. Adverse influence of cigarette smoking on the endothelium
60. Role of blood pressure in cardiovascular disease: the Framingham Study
61. Hypertension, endothelium, and cardiovascular risk factors
62. Increased level of factor VIII complex in severe arterial hypertension
63. von Willebrand factor and endothelial damage in essential hypertension
64. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,622 men
65. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity
66. Increased von Willebrand factor antigen in familial hypercholesterolaemia with or without vascular disease
67. Increased von Willebrand factor antigen in polygenic hypercholesterolaemia with or without vascular disease
68. von Willebrand factor concentrations in patients receiving a lipid lowering diet
69. Reduction in cholesterol is associated with reduction in von Willebrand factor
70. Oxidised lipoproteins are cytotoxic to endothelial cells in vitrol
71. von Willebrand factor, the endothelium, and obesity
72. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction-expression of acute phase reaction or index of vascular endothelium damage?
73. Vascular damage and factor VIII related antigen in the rheumatic diseases
74. 2-antiplasmin in peripheral arterial disease
75. Blood coagulation studies in 45 patients with ischaemic cerebrovascular disease and 44 patients with venous thromboembolic disease
76. A study of hemostasis in ischemic cerebrovascular disease I. Abnormalities in factor VIII and antithrombin
77. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein
78. Increased factor VIII related antigen in cerebral thrombosis
79. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction
80. The PLAT study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients
81. The PLAT study. Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results
82. Occurrence of arteriosclerosis in von Willebrand's disease
83. Autopsy findings in three patients with von Willebrand disease: presence of atherosclerotic lesions without occlusive arterial thrombi
84. Prediction of outcome in intra-inguinal bypass grafting
85. von Willebrand factor in atherosclerotic vascular disease
86. Raised factor VIII related antigen in scleroderma. Is it of diagnostic or prognostic significance?
87. High von Willebrand factor antigen levels are associated with increased mortality in connective tissue diseases
88. von Willebrand factor in plasma as risk indicator for cardiovascular events
89. Endothelial cell damage in rheumatoid disease correlates with complement consumption and immune complexes
90. von Willebrand as a marker of injury to the endothelium in inflammatory vascular disease
91. Blockade of von Willebrand factor-platelet GPIb interaction prevents reocclusion following arterial thrombolysis
92. Interaction of von Willebrand factor with heparin: effect of binding to platelet glycoprotein lb
93. Heparin